142 related articles for article (PubMed ID: 9264282)
1. Correspondence re: A. Manetta et al., Beta-carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol., Biomarkers & Prev., 5: 929-932, 1996.
Torné A; Puig-Tintoré LM; Ordi J; Sánchez E
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):655-6. PubMed ID: 9264282
[No Abstract] [Full Text] [Related]
2. beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study.
Manetta A; Schubbert T; Chapman J; Schell MJ; Peng YM; Liao SY; Meyskens FJ
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):929-32. PubMed ID: 8922303
[TBL] [Abstract][Full Text] [Related]
3. Distribution of cervical intraepithelial neoplasia 2, 3 and cancer on the uterine cervix.
Pretorius RG; Zhang X; Belinson JL; Zhang WH; Ren SD; Bao YP; Qiao YL
J Low Genit Tract Dis; 2006 Jan; 10(1):45-50. PubMed ID: 16378031
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.
Keefe KA; Schell MJ; Brewer C; McHale M; Brewster W; Chapman JA; Rose GS; McMeeken DS; Lagerberg W; Peng YM; Wilczynski SP; Anton-Culver H; Meyskens FL; Berman ML
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1029-35. PubMed ID: 11588128
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
Geisler S; Speiser S; Speiser L; Heinze G; Rosenthal A; Speiser P
Obstet Gynecol; 2016 Feb; 127(2):353-9. PubMed ID: 26942365
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Boiko IV; Mitchell MF; Hu W; Pandey DK; Mathevet P; Malpica A; Hittelman WN
Clin Cancer Res; 1998 Jun; 4(6):1383-91. PubMed ID: 9626454
[TBL] [Abstract][Full Text] [Related]
7. Cone biopsy and hysterectomy in the management of cervical intraepithelial neoplasia.
Jones HW
Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):221-36. PubMed ID: 7600728
[No Abstract] [Full Text] [Related]
8. [Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ) of the cervix].
Heim K; Müller-Holzner E; Pinzger G; Holböck E; Wartusch B
Gynakol Rundsch; 1989; 29 Suppl 2():407-9. PubMed ID: 2613064
[No Abstract] [Full Text] [Related]
9. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
10. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II clinical safety studies of terameprocol vaginal ointment.
Khanna N; Dalby R; Tan M; Arnold S; Stern J; Frazer N
Gynecol Oncol; 2007 Dec; 107(3):554-62. PubMed ID: 17905420
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic HPV vaccine for cervical intraepithelial neoplasia.
Burki TK
Lancet Oncol; 2019 May; 20(5):e250. PubMed ID: 30987938
[No Abstract] [Full Text] [Related]
13. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
[TBL] [Abstract][Full Text] [Related]
14. Morphometric evaluation of nucleolar organizer regions in cervical intraepithelial neoplasia.
Sakai YI; Sakai AT; Isotani S; Cavaliere MJ; de Almeida LV; Calore EE
Pathol Res Pract; 2001; 197(3):189-92. PubMed ID: 11314783
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
16. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial.
Garcia F; Petry KU; Muderspach L; Gold MA; Braly P; Crum CP; Magill M; Silverman M; Urban RG; Hedley ML; Beach KJ
Obstet Gynecol; 2004 Feb; 103(2):317-26. PubMed ID: 14754702
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence detection of cervical intraepithelial neoplasia for photodynamic therapy with the topical agents 5-aminolevulinic acid and benzoporphyrin-derivative monoacid ring.
Keefe KA; Chahine EB; DiSaia PJ; Krasieva TB; Lin F; Berns MW; Tadir Y
Am J Obstet Gynecol; 2001 May; 184(6):1164-9. PubMed ID: 11349183
[TBL] [Abstract][Full Text] [Related]
18. [Directed colposcopic-cytologic diagnosis in cervical intraepithelial neoplasia (CIN) (author's transl)].
Naujoks H; Leber I; Humke R
Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):468-71. PubMed ID: 6921129
[No Abstract] [Full Text] [Related]
19. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
Hillemanns P; Garcia F; Petry KU; Dvorak V; Sadovsky O; Iversen OE; Einstein MH
Am J Obstet Gynecol; 2015 Apr; 212(4):465.e1-7. PubMed ID: 25467012
[TBL] [Abstract][Full Text] [Related]
20. [The value of colposcopy in assessment of intraepithelial neoplasia of the lower genital tract].
Heinzl S
Arch Gynecol Obstet; 1995; 257(1-4):425-30. PubMed ID: 8579424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
